John Abraham
School of Social Sciences
University of Sussex
Arts E Building Falmer
Brighton BN19QN
United Kingdom
Name/email consistency: high
- On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin. Abraham, J. Soc. Sci. Med (2010)
- Drug evaluation and the permissive principle: continuities and contradictions between standards and practices in antidepressant regulation. Abraham, J., Davis, C. Soc. Stud. Sci (2009)
- Global health challenges in the pharmaceutical world. Abraham, J. Health. Economics,. Policy,. Law (2009)
- The politics and bio-ethics of regulatory trust: case-studies of pharmaceuticals. Abraham, J. Med. Health. Care. Philos (2008)
- Sociology of pharmaceuticals development and regulation: a realist empirical research programme. Abraham, J. Sociol. Health. Illn (2008)
- Testing times: the emergence of the practolol disaster and its challenge to British drug regulation in the modern period. Abraham, J., Davis, C. Soc. Hist. Med (2006)
- A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy. Abraham, J., Davis, C. Soc. Sci. Med (2005)
- Pharmaceuticals, the state and the global harmonisation process. Abraham, J. Aust. Health. Rev (2004)
- The science and politics of medicines control. Abraham, J. Drug. Saf (2003)
- Reshaping the carcinogenic risk assessment of medicines: international harmonisation for drug safety, industry/regulator efficiency or both?. Abraham, J., Reed, T. Soc. Sci. Med (2003)
- Progress, innovation and regulatory science in drug development: the politics of international standard-setting. Abraham, J., Reed, T. Soc. Stud. Sci (2002)
- Transnational industrial power, the medical profession and the regulatory state: adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UK. Abraham, J. Soc. Sci. Med (2002)
- The pharmaceutical industry as a political player. Abraham, J. Lancet (2002)
- Regulatory science as culture: contested two-dimensional values at the US FDA. Abraham, J. Sci. Cult. (Lond) (2002)
- Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval?. Abraham, J., Lewis, G. Soc. Sci. Med (1999)
- Rethinking transparency and accountability in medicines regulation in the United Kingdom. Abraham, J., Sheppard, J., Reed, T. BMJ (1999)
- Secrecy and transparency of medicines licensing in the EU. Abraham, J., Lewis, G. Lancet (1998)